Wear it pink on 24 October Wear pink. Raise money. Help make life-changing breast cancer research and support happen.
Home About us Media Breast Cancer Now media statements 215 results We respond to new guidelines for the treatment of secondary breast cancer agreed at the Advanced Breast Cancer Sixth International Consensus Conference (ABC 6) 07 Nov 2021 2 min read We respond to new survey results from the ABC6 Conference titled “Advanced breast cancer patients denied opportunities to join clinical trials. Patient advocate calls for collaboration to improve access to trials” 04 Nov 2021 1 min read We respond to new research titled “Major global study reveals risk of breast cancer spreading to other parts of the body" 03 Nov 2021 1 min read We respond to draft NICE decision to not recommend tucatinib with trastuzumab and capecitabine for routine use on the NHS 26 Oct 2021 2 min read We respond to Macmillan Cancer Support's warning of 'perfect storm' of Covid and staff shortages 22 Oct 2021 1 min read We respond to a new study into eating nuts and breast cancer recurrence 20 Oct 2021 1 min read We respond to a report from the IPPR and CF suggesting it could take over a decade to clear the cancer treatment backlog in England 24 Sept 2021 1 min read We respond to new data for Enhertu presented at the European Society for Medical Oncology conference 19 Sept 2021 1 min read We respond to news of NHS England and Amgen reaching a national agreement to enable early access to Sotorasib for eligible lung cancer patients in England 10 Sept 2021 1 min read We respond to Macmillan Cancer Support's new research revealing severe nurse shortages are putting cancer patients at risk 08 Sept 2021 1 min read Breast Cancer Now welcomes NICE approval of abemaciclib with fulvestrant for routine use on the NHS 12 Aug 2021 3 min read We respond to a new study into the use of ErSO to shrink oestrogen receptor positive breast cancer in mice 22 Jul 2021 1 min read Previous 1 ... 15 ... 18 Next
We respond to new guidelines for the treatment of secondary breast cancer agreed at the Advanced Breast Cancer Sixth International Consensus Conference (ABC 6) 07 Nov 2021 2 min read
We respond to new survey results from the ABC6 Conference titled “Advanced breast cancer patients denied opportunities to join clinical trials. Patient advocate calls for collaboration to improve access to trials” 04 Nov 2021 1 min read
We respond to new research titled “Major global study reveals risk of breast cancer spreading to other parts of the body" 03 Nov 2021 1 min read
We respond to draft NICE decision to not recommend tucatinib with trastuzumab and capecitabine for routine use on the NHS 26 Oct 2021 2 min read
We respond to Macmillan Cancer Support's warning of 'perfect storm' of Covid and staff shortages 22 Oct 2021 1 min read
We respond to a report from the IPPR and CF suggesting it could take over a decade to clear the cancer treatment backlog in England 24 Sept 2021 1 min read
We respond to new data for Enhertu presented at the European Society for Medical Oncology conference 19 Sept 2021 1 min read
We respond to news of NHS England and Amgen reaching a national agreement to enable early access to Sotorasib for eligible lung cancer patients in England 10 Sept 2021 1 min read
We respond to Macmillan Cancer Support's new research revealing severe nurse shortages are putting cancer patients at risk 08 Sept 2021 1 min read
Breast Cancer Now welcomes NICE approval of abemaciclib with fulvestrant for routine use on the NHS 12 Aug 2021 3 min read
We respond to a new study into the use of ErSO to shrink oestrogen receptor positive breast cancer in mice 22 Jul 2021 1 min read
